HYPERAMMONEMIA IS ASSOCIATED WITH INCREASING SEVERITY OF BOTH LIVER CIRRHOSIS AND HEPATIC ENCEPHALOPATHY

A NAWAZ; . MAAZ; R BHATTI; A SHAHZAD; HU HAQ

doi:10.54112/bcsrj.v2024i1.998

Authors

A NAWAZ DHQ Hospital Nowshera, Khyber Pakhtunkhwa, Pakistan
. MAAZ DHQ Hospital Lakki Marwat, Pakistan
R BHATTI Asian Institute of Medical Sciences Hyderabad, Pakistan
A SHAHZAD Department Of Gastroenterology FUSH Rawalpindi, Pakistan
HU HAQ Department Of Medicine FUSH Rawalpindi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.998

Keywords:

Ammonia, Hepatic Encephalopathy, Liver Cirrhosis, Hyperammonemia, Child-Pugh Score

Abstract

Hyperammonemia is a critical condition frequently observed in patients with liver cirrhosis and hepatic encephalopathy. Objectives: The study's main aim is to find that hyperammonemia is associated with increasing severity of both liver cirrhosis and hepatic encephalopathy. Methods: This retrospective cohort study was conducted at DHQ Hospital Nowshera Khyber Pakhtunkhwa from January 2023 to June 2023. A total of 175 patients diagnosed with liver cirrhosis were included in the study. Data collection was performed using the hospital's electronic medical records system. The variables collected included demographic data like patients’ age and sex and clinical data concerning the etiology of cirrhosis, Child-Pugh score, and MELD score. Results: The study included 175 patients with liver cirrhosis, with a mean age of 54.3 ± 12.7 years, of whom 64% were male and 36% female. The etiologies of cirrhosis were predominantly hepatitis C virus (45%), hepatitis B virus (30%), alcoholic liver disease (15%), and non-alcoholic steatohepatitis (10%). The mean Child-Pugh score was 8.7 ± 2.1, indicating moderate to severe liver disease, and the mean MELD score was 14.3 ± 4.5. The study found a strong positive correlation between ammonia levels and encephalopathy severity (r = 0.72, p < 0.001). Conclusion: It is concluded that hyperammonemia is significantly associated with the severity of liver cirrhosis and hepatic encephalopathy.

Downloads

Download data is not yet available.

References

Khan A, Ayub M, Khan WM. Hyperammonemia is associated with increasing severity of both liver cirrhosis and hepatic encephalopathy. International journal of hepatology. 2016;2016(1):6741754.

Jacoby KJ, Singh P, Prekker ME, Leatherman JW. Characteristics and outcomes of critically ill patients with severe hyperammonemia. Journal of Critical Care. 2020;56:177-81.

Kalra A, Norvell J. Cause for confusion: noncirrhotic hyperammonemic encephalopathy. Clinical Liver Disease. 2020;15(6):223-7.

Nadinskaia MY, Maevskaya MV, Bakulin IG, Bessonova EN, Bueverov AO, Zharkova MS, et al. Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement). morbidity, and mortality. 2024;31:32.

Montes-Cortes DH, Olivares-Corichi IM, Rosas-Barrientos JV, Manuel-Apolinar L, Martìnez-Godinez MdlA, Hernández-López JC, et al. Characterization of oxidative stress and ammonia according to the different grades of hepatic encephalopathy. Digestive Diseases. 2020;38(3):240-50.

García-Martínez R, Diaz-Ruiz R, Poncela M. Management of hepatic encephalopathy associated with advanced liver disease. Clinical Drug Investigation. 2022;42(Suppl 1):5-13.

Verma N, Dhiman RK, Choudhury A, Taneja S, Duseja A, Singh V, et al. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure. Hepatology International. 2021;15:970-82.

Jaffe A, Lim JK, Jakab SS. Pathophysiology of hepatic encephalopathy. Clinics in Liver Disease. 2020;24(2):175-88.

Kerbert AJ, Jalan R. Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease. F1000Research. 2020;9.

Shalimar, Rout G, Kumar R, Singh AD, Sharma S, Gunjan D, et al. Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute‐on‐chronic liver failure. JGH Open. 2020;4(5):843-50.

Butterworth RF. Ammonia removal by metabolic scavengers for the prevention and treatment of hepatic encephalopathy in cirrhosis. Drugs in R&D. 2021;21(2):123-32.

Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, et al. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. Journal of hepatology. 2020;73(6):1526-47.

Warrillow S, Fisher C, Bellomo R. Correction and control of hyperammonemia in acute liver failure: the impact of continuous renal replacement timing, intensity, and duration. Critical care medicine. 2020;48(2):218-24.

Rudler M, Weiss N, Bouzbib C, Thabut D. Diagnosis and management of hepatic encephalopathy. Clinics in liver disease. 2021;25(2):393-417.

Zhao L, Walline JH, Gao Y, Lu X, Yu S, Ge Z, et al. Prognostic role of ammonia in critical care patients without known hepatic disease. Frontiers in Medicine. 2020;7:589825.

Lu K. Cellular pathogenesis of hepatic encephalopathy: An update. Biomolecules. 2023;13(2):396.

Duarte T, Fidalgo P, Karvellas CJ, Cardoso FS. What every Intensivist should know about the role of ammonia in liver failure. Journal of Critical Care. 2023:154456.

Häussinger D, Butz M, Schnitzler A, Görg B. Pathomechanisms in hepatic encephalopathy. Biological Chemistry. 2021;402(9):1087-102.

DeMorrow S, Cudalbu C, Davies N, Jayakumar AR, Rose CF. 2021 ISHEN guidelines on animal models of hepatic encephalopathy. Liver International. 2021;41(7):1474-88.